Trial Identifiers
Use the hyperlinks, where available to access additional clinical trial information.
Trial sponsor
AbbVie
Scientific Title
A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of Rovalpituzumab Tesirine as Maintenance Therapy Following First-Line Platinum-Based Chemotherapy in Subjects With Extensive Stage Small Cell Lung Cancer